Dianthus Therapeutics, Inc. (DNTH)
NASDAQ · Manufacturing · Pharmaceutical preparations
DNTH price, last 12 months
Key stats
- Previous close
- $83.98
- Open
- $84.33
- Day range
- $83.25 – $87.12
- 52-week range
- $35.84 – $117.88
- Volume
- 896.8K
- Avg volume (20 days)
- 793.5K
- Market cap
- $5.2B
Performance
Technicals and fundamentals
About Dianthus Therapeutics, Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $5.2B